Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yishuo Sun

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
ACS Applied Materials & Interfaces|June 8, 2023
Tunable Afterglow System Linna Guo, Yishuo Sun, Xianlong Su, et al.
Oncogene|April 29, 2026
MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progressionZiwei Li, Chunfa Wu, Zhongliang Cui, et al.
Med (New York, N.Y.)|October 23, 2025
Strategy and clinical benefit of first re-resection for recurrent adult-type diffuse glioma: A retrospective cohort analysisCheng Cheng, Chongshun Zhao, Bo Liang, et al.
Theranostics|November 24, 2025
Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activityChangqing Pan, You Zhai, Zhongliang Cui, et al.
Cancer Research|March 26, 2026
A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma MutationsChen Wang, Ting Sun, Yufei He, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
ACS Applied Materials & Interfaces|June 8, 2023
Tunable Afterglow System Linna Guo, Yishuo Sun, Xianlong Su, et al.
Oncogene|April 29, 2026
MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progressionZiwei Li, Chunfa Wu, Zhongliang Cui, et al.
Med (New York, N.Y.)|October 23, 2025
Strategy and clinical benefit of first re-resection for recurrent adult-type diffuse glioma: A retrospective cohort analysisCheng Cheng, Chongshun Zhao, Bo Liang, et al.
Theranostics|November 24, 2025
Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activityChangqing Pan, You Zhai, Zhongliang Cui, et al.
Cancer Research|March 26, 2026
A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma MutationsChen Wang, Ting Sun, Yufei He, et al.
Pageof 2